Literature DB >> 15996838

Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.

J Hecq1, M Deleers, D Fanara, H Vranckx, K Amighi.   

Abstract

Poorly water-soluble drugs such as nifedipine (NIF) (approximately 20 microg/ml) offer challenging problems in drug formulation as poor solubility is generally associated to poor dissolution characteristics and thus to poor oral bioavailability. In order to enhance these characteristics, preparation of nifedipine nanoparticles has been achieved using high pressure homogenization. The homogenization procedure has first been optimized in regard to particle size and size distribution. Nanoparticles were characterized in terms of size, morphology and redispersion characteristics following water-removal. Saturation solubility and dissolution characteristics were investigated and compared to the un-milled commercial NIF to verify the theoretical hypothesis on the benefit of increased surface area. Crystalline state evaluation before and following particle size reduction was also conducted through differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) to denote eventual transformation to amorphous state during the homogenization process. Through this study, it has been shown that initial crystalline state is maintained following particle size reduction and that the dissolution characteristics of nifedipine nanoparticles were significantly increased in regards to the commercial product. The method being simple and easily scaled up, this approach should have a general applicability to many poorly water-soluble drug entities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996838     DOI: 10.1016/j.ijpharm.2005.05.014

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  30 in total

1.  Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates.

Authors:  Sindhuri Maddineni; Sunil Kumar Battu; Joe Morott; Soumyajit Majumdar; S N Murthy; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2014-11-01       Impact factor: 3.246

2.  What is a suitable dissolution method for drug nanoparticles?

Authors:  Desmond Heng; David J Cutler; Hak-Kim Chan; Jimmy Yun; Judy A Raper
Journal:  Pharm Res       Date:  2008-03-05       Impact factor: 4.200

3.  The role of particle size of glyburide crystals in improving its oral absorption.

Authors:  Wenqian Yang; Yongjun Wang; Qiang Fu; Zhibin Guo; Bingjun Sun; Wen Liu; Yaxuan Liu; Simeng Mu; Mengran Guo; Jingru Li; Xiaohui Pu; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

4.  Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Authors:  Nathalie Wauthoz; Philippe Deleuze; Amandine Saumet; Christophe Duret; Robert Kiss; Karim Amighi
Journal:  Pharm Res       Date:  2010-11-30       Impact factor: 4.200

Review 5.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

6.  Bi-polymeric Spongy Matrices Through Cross-linking Polymerization: Synthesized and Evaluated for Solubility Enhancement of Acyclovir.

Authors:  Saima Asghar; Naveed Akhtar; Muhammad Usman Minhas; Kifayat Ullah Khan
Journal:  AAPS PharmSciTech       Date:  2021-06-15       Impact factor: 3.246

7.  Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.

Authors:  H Lou; M Liu; L Wang; S R Mishra; W Qu; J Johnson; E Brunson; H Almoazen
Journal:  AAPS PharmSciTech       Date:  2013-06-13       Impact factor: 3.246

8.  Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.

Authors:  Jiao Sun; Fan Wang; Yue Sui; Zhennan She; Wenjun Zhai; Chunling Wang; Yihui Deng
Journal:  Int J Nanomedicine       Date:  2012-11-12

9.  Use of Bead Mixtures as a Novel Process Optimization Approach to Nanomilling of Drug Suspensions.

Authors:  Gulenay Guner; Manisha Kannan; Matthew Berrios; Ecevit Bilgili
Journal:  Pharm Res       Date:  2021-06-24       Impact factor: 4.200

10.  New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Int J Nanomedicine       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.